Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Li, Heng Hong ^a   Doiron, Kathryn ^a   Patterson, Andrew D ^b   Gonzalez, Frank J ^c   Fornace, Albert J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alcohol induced liver disease; Biomarker; Igfbp1; IGFBP1 protein; Transcriptomics

Indexed keywords

ALCOHOL; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 1;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GENE EXPRESSION; IGFBP1 GENE; LIVER; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RNA EXTRACTION; TRANSCRIPTOMICS;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER DISEASES, ALCOHOLIC; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84886005176     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-266     Document Type: Article

References (38)

1. Minino AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep 2011, 59:1-126.
2. Yamauchi M, Hirakawa J, Maezawa Y, Nishikawa F, Mizuhara Y, Ohata M, Nakajima H, Toda G. Serum level of carbohydrate-deficient transferrin as a marker of alcoholic liver disease. Alcohol Alcohol Suppl 1993, 1B:3-8.
3. Neumann T, Spies C. Use of biomarkers for alcohol use disorders in clinical practice. Addict 2003, 98(Suppl 2):81-91.
4. Schmitt UM, Stieber P, Jungst D, Bilzer M, Wachtler M, Heberger S, Seidel D. Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest 1998, 28:615-621. 10.1046/j.1365-2362.1998.00343.x, 9767355.
5. Karkkainen P, Poikolainen K, Salaspuro M. Serum beta-hexosaminidase as a marker of heavy drinking. Alcohol Clin Exp Res 1990, 14:187-190. 10.1111/j.1530-0277.1990.tb00469.x, 1972003.
6. Karkkainen P, Salaspuro M. Beta-hexosaminidase in the detection of alcoholism and heavy drinking. Alcohol Alcohol Suppl 1991, 1:459-464.
7. Ledig M, Doffoel M, Doffoel S, Kopp P, Bockel R, Mandel P. Blood cell superoxide dismutase and enolase activities as markers of alcoholic and nonalcoholic liver diseases. Alcohol 1988, 5:387-391. 10.1016/0741-8329(88)90025-0, 3219186.
8. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, Carpenter SP. Human lymphocyte cytochrome p450 2e1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 1997, 25:1429-1435.
9. Bradford BU, OConnell TM, Han J, Kosyk O, Shymonyak S, Ross PK, Winnike J, Kono H, Rusyn I. Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol 2008, 232:236-243. 10.1016/j.taap.2008.06.022, 2583460, 18674555.
10. Manna SK, Patterson AD, Yang Q, Krausz KW, Idle JR, Fornace AJ, Gonzalez FJ. Uplc-ms-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the ppara-null mouse model. J Proteome Res 2011, 10:4120-4133. 10.1021/pr200310s, 3170755, 21749142.
11. Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. Methods Enzymol 1994, 233:585-594.
12. la MHP D, Lieber CS, DeCarli LM, French SW, Lindros KO, Jarvelainen H, Bode C, Parlesak A, Bode JC. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res 2001, 25:254S-261S. 10.1111/j.1530-0277.2001.tb02405.x, 11391080.
13. Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC, Largman C. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatol 1985, 5:224-232.
14. Ueno A, Lazaro R, Wang PY, Higashiyama R, Machida K, Tsukamoto H. Mouse intragastric infusion (ig) model. Nat Protoc 2012, 7:771-781. 10.1038/nprot.2012.014, 22461066.
15. Fritz KS, Galligan JJ, Hirschey MD, Verdin E, Petersen DR. Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing sirt3 knockout mice. J Proteome Res 2012, 11:1633-1643. 10.1021/pr2008384, 3324946, 22309199.
16. Yang L, Wu D, Wang X, Cederbaum AI. Cytochrome p4502e1, oxidative stress, jnk, and autophagy in acute alcohol-induced fatty liver. Free Radic Biol Med 2012, 53:1170-1180. 10.1016/j.freeradbiomed.2012.06.029, 3432162, 22749809.
17. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatol 2004, 40:972-980.
18. Deaciuc IV, Doherty DE, Burikhanov R, Lee EY, Stromberg AJ, Peng X, de Villiers WJ. Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion. J Hepatol 2004, 40:219-227. 10.1016/j.jhep.2003.10.021, 14739091.
19. Deaciuc IV, Peng X, DSouza NB, Shedlofsky SI, Burikhanov R, Voskresensky IV, de Villiers WJ. Microarray gene analysis of the liver in a rat model of chronic, voluntary alcohol intake. Alcohol 2004, 32:113-127. 10.1016/j.alcohol.2003.12.001, 15163562.
20. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterol 2003, 124:1488-1499.
21. Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T. Hepatitis c virus core protein activates erk and p38 mapk in cooperation with ethanol in transgenic mice. Hepatol 2003, 38:820-828.
22. Seth D, Leo MA, McGuinness PH, Lieber CS, Brennan Y, Williams R, Wang XM, McCaughan GW, Gorrell MD, Haber PS. Gene expression profiling of alcoholic liver disease in the baboon (papio hamadryas) and human liver. Am J Pathol 2003, 163:2303-2317. 10.1016/S0002-9440(10)63587-0, 1892389, 14633604.
23. Tadic SD, Elm MS, Li HS, Van Londen GJ, Subbotin VM, Whitcomb DC, Eagon PK. Sex differences in hepatic gene expression in a rat model of ethanol-induced liver injury. J Appl Physiol 2002, 93:1057-1068.
24. Manna SK, Patterson AD, Yang Q, Krausz KW, Li H, Idle JR, Fornace AJJ, Gonzalez FJ. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the ppara-null mouse. J Proteome Res 2010, 9:4176-4188. 10.1021/pr100452b, 2917755, 20540569.
25. Lynch JL, de Silva CJ, Peeva VK, Swanson NR. Comparison of commercial probe labeling kits for microarray: towards quality assurance and consistency of reactions. Anal Biochem 2006, 355:224-231. 10.1016/j.ab.2006.04.052, 16737680.
26. Eichler GS, Huang S, Ingber DE. Gene expression dynamics inspector (gedi): for integrative analysis of expression profiles. Bioinformatics 2003, 19:2321-2322. 10.1093/bioinformatics/btg307, 14630665.
27. Deaciuc IV, Song Z, McClain CJ. Lessons from large-scale gene profiling of the liver in alcoholic liver disease. Hepatol Res 2005, 31:187-192. 10.1016/j.hepres.2005.02.004, 16890166.
28. Karp NA, Lilley KS. Investigating sample pooling strategies for dige experiments to address biological variability. Proteomic 2009, 9:388-397.
29. Macgregor S. Most pooling variation in array-based DNA pooling is attributable to array error rather than pool construction error. Eur J Hum Genet 2007, 15:501-504. 10.1038/sj.ejhg.5201768, 17264871.
30. Jolly RA, Goldstein KM, Wei T, Gao H, Chen P, Huang S, Colet JM, Ryan TP, Thomas CE, Estrem ST. Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Physiol Genomics 2005, 22:346-355. 10.1152/physiolgenomics.00260.2004, 15914576.
31. Knip M, Ekman AC, Ekman M, Leppaluoto J, Vakkuri O. Ethanol induces a paradoxical simultaneous increase in circulating concentrations of insulin-like growth factor binding protein-1 and insulin. Metab 1995, 44:1356-1359.
32. Rojdmark S, Rydvald Y, Aquilonius A, Brismar K. Insulin-like growth factor (igf)-1 and igf-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased igf-1 bioavailability. Clin Endocrinol (Oxf) 2000, 52:313-318. 10.1046/j.1365-2265.2000.00908.x, 10718829.
33. Rojdmark S, Brismar K. Decreased igf-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence. J Endocrinol Invest 2001, 24:476-482.
34. Gronbaek H, Flyvbjerg A, Winding P, Frystyk J, Hey H. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects. Growth Horm IGF Res 2005, 15:243-250. 10.1016/j.ghir.2005.03.003, 15925526.
35. Nedic O, Nikolic JA, Hajdukovic-Dragojlovic L, Todorovic V, Masnikosa R. Alterations of igf-binding proteins in patients with alcoholic liver cirrhosis. Alcohol 2000, 21:223-229. 10.1016/S0741-8329(00)00090-2, 11091025.
36. Lang CH, Fan J, Lipton BP, Potter BJ, McDonough KH. Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 1998, 22:823-829. 10.1111/j.1530-0277.1998.tb03874.x, 9660307.
37. Kumar V, Silvis C, Nystrom G, Deshpande N, Vary TC, Frost RA, Lang CH. Alcohol-induced increases in insulin-like growth factor binding protein-1 are partially mediated by tnf. Alcohol Clin Exp Res 2002, 26:1574-1583. 10.1111/j.1530-0277.2002.tb02458.x, 12394292.
38. Graffigna MN, Belli SH, de Larranaga G, Fainboim H, Estepo C, Peres S, Garcia N, Levalle O. Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?. Acta Gastroenterol Latinoam 2009, 39:30-37.